IOL Chemicals & Pharmaceuticals IOLCP
One of the world's largest ibuprofen makers, integrated back into KSMs and basic chemicals (isobutylbenzene, ethyl acetate)
Mapped in 1 theme: Pharmaceuticals.
Where IOL Chemicals & Pharmaceuticals sits in the supply chain
IOL Chemicals & Pharmaceuticals appears in 1 supply-chain layer in one theme, Pharmaceuticals.
Pharmaceuticals › KSMs & intermediates
Direct supplierOther companies in this layer
Revenue and profit
| ₹ Cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 2,133 | 2,079 | 2,319 |
| Net profit | 134 | 101 | 138 |
Latest-year revenue ₹2,319 Cr (FY26, company-wide). Wider screens show FY22 onwards.
Strengths
- Integration from basic chemicals to ibuprofen API gives cost control
- Diversifying into new APIs
Risks
- Single-molecule (ibuprofen) concentration and Chinese pricing
- Flat revenue and falling profit FY22-FY25
Common questions
What does IOL Chemicals & Pharmaceuticals do?
One of the world's largest ibuprofen makers, integrated back into KSMs and basic chemicals (isobutylbenzene, ethyl acetate).
Where does IOL Chemicals & Pharmaceuticals sit in the supply chain?
IOL Chemicals & Pharmaceuticals (NSE: IOLCP) is mapped in 1 supply-chain layer: KSMs & intermediates (Pharmaceuticals).
Who are IOL Chemicals & Pharmaceuticals' peers?
In the KSMs & intermediates layer of Pharmaceuticals: Vinati Organics, Aarti Pharmalabs, Aarti Drugs, Granules India and Aurobindo Pharma.
What is IOL Chemicals & Pharmaceuticals' market cap and valuation?
As of 30 Oct 2026: market cap ₹5,217 Cr, P/E 29.6x, ROCE 11.3%, ROE 8.4%, dividend yield 0.56%.